 Adaptive Biotechnologies Corporation NASDAQ: ADPT will be organized around two distinct business areas - Minimal Residual Disease MRD and Immune Medicine. Adaptives MRD business includes clonoSEQ diagnostic tests for clinicians and the clonoSEQ assay for pharmaceutical partners to. 